Maine Medicine Weekly Update - Maine Medicine Weekly Update
October 18, 2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
LEAD STORY
•  FDA Advisory Committee Recommends Moderna, J&J Boosters. What You Need to Know
More COVID Guidance & News
•  Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds
•  Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients
•  FDA Schedules Advisory Committee Meeting to Discuss COVID-19 Oral Treatment
•  Federal COVID Vaccine Mandate Rules Have Been Drafted
Maine Health System News
•  Central Maine Healthcare Services, Staffing, Vaccine Mandate, CEO Appointment
Clinical News
•  New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke
•  Top JAMA, JAMA Network, and New England Journal of Medicine Articles
Physician Well Being
•  Using Electronic Health Records to Predict Physician Departure
Webinars
•  Preventing Stimulant Misuse Among College-Aged Students
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  SUPPORT for ME Training and Technical Assistance Initiative
•  SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1
•  Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)
•  Physician (BC/BE in Family Medicine) - Bingham Area Health Center

 

New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke

Draft guidelines from the United States Preventative Service Task Force advises physicians to stop prescribing regular low doses of aspirin to patients at risk of a first heart attack or stroke. The new information amends the task force’s 2016 recommendation of initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD).


Draft guidelines from the United States Preventative Service Task Force advises physicians to stop prescribing regular low doses of aspirin to patients at risk of a first heart attack or stroke. The new information amends the task force’s 2016 recommendation of initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD).

---

Click here to read to read the media release and additional background: Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease (PDF)

The Task Force is seeking comments on its draft recommendation statement, draft evidence review, and draft modeling report on aspirin use to prevent cardiovascular disease. People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 and older should not start taking aspirin. The draft recommendation statement, draft evidence review, and draft modeling report are available for review and public comment from October 12, 2021 to November 8, 2021 here.